Printer Friendly

Caremark Selected Provider for Aralast.

Business Editors/Health/Medical Writers


Caremark Rx, Inc. (NYSE: CMX) today announced that its affiliate, Caremark Inc. has been selected by Baxter Healthcare Corporation, as one of three providers of Aralast(TM), a new alpha-1 proteinase inhibitor (human).

Aralast(TM) is the second in a class of therapies that serves to treat individuals with alpha-1 proteinase inhibitor deficiency or A1PI.

Caremark specialty pharmacy programs not only provide timely, accurate and confidential dispensing of medications through a network of 17 specialty pharmacies accredited by the Joint Commission on Accreditation of Healthcare Organizations (JCAHO), but also improve outcomes through proactive compliance and persistency monitoring, disease education and pharmacy care management programs.

About Caremark Rx, Inc.

Caremark Rx, Inc. is a leading pharmaceutical services company, providing comprehensive drug benefit services through its affiliate Caremark Inc. to over 1,200 health plan sponsors and their participants throughout the U.S. Caremark's clients include corporate health plans, managed care organizations, insurance companies, unions, government agencies and other funded benefit plans. The company operates a national retail pharmacy network with over 55,000 participating pharmacies, four state-of-the-art mail service pharmacies, the industry's only FDA-regulated repackaging plant and nineteen specialty distribution mail service pharmacies for delivery of advanced medications to individuals with chronic or genetic diseases and disorders.

Additional information about Caremark Rx is available on the World Wide Web at

Aralast(TM) is a trademark of Alpha Therapeutic Corporation
COPYRIGHT 2003 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jun 4, 2003
Previous Article:S&P Assigns SLM Student Loan Trust 2003-6 Prelim Rtgs.
Next Article:The Aristotle Corporation Acquires Haan Crafts Corporation.

Related Articles
Michelle Hooper.
Caremark to Present at Deutsche Bank 28th Annual Healthcare Conference.
Caremark Rx Scheduled to Hold Annual Investor Conference Friday, May 16, 2003.
Caremark Rx Selected as Preferred Distributor in the Specialty Pharmacy Network for Xolair.
Caremark to Present at Goldman Sachs 24th Annual Healthcare Conference.
Caremark Rx Announces Second Quarter 2003 Earnings Release Date July 30, 2003.
Caremark Rx Selected as Part of the Distribution Network for Raptiva.
Caremark Rx, Inc. to Present Jointly with AdvancePCS at the Credit Suisse First Boston Healthcare Conference.
Caremark Rx Issues Statement Refuting Accusations Made by Certain Florida Relators.
Caremark Responds to Express Scripts' Statement.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters